100% Quality Guarantee
PhD-Level Technical Support
Key Features

Tidutamab Biosimilar (SSTR2) Antibody (HDBS0106)

SKU HDBS0106
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein SSTR2
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Tidutamab Biosimilar (SSTR2) Antibody (HDBS0106)

The Tidutamab Biosimilar SSTR2 Antibody is a groundbreaking product designed for research involving the SSTR2 receptor, a key target in cancer therapy. This monoclonal antibody, produced using cutting-edge technology, specifically targets the SSTR2 receptor, which plays a crucial role in regulating tumor growth and hormone production in various cancers.Validated for use in various applications, including immunohistochemistry and flow cytometry, this antibody is highly specific and sensitive, ensuring accurate detection and analysis of SSTR2 expression in cell lines and tissue samples. Its ability to bind exclusively to the SSTR2 receptor makes it an invaluable tool for studying the role of this receptor in cancer progression and developing targeted therapies.

With its potential applications in cancer research and drug development, the Tidutamab Biosimilar Anti-SSTR2 Antibody offers researchers a powerful tool for investigating the mechanisms underlying SSTR2-mediated signaling pathways and exploring novel treatment strategies for SSTR2-expressing tumors. Stay ahead in your research with this innovative antibody designed to accelerate advances in cancer biology and therapeutics.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose